Skip to main content
Top
Published in: BMC Health Services Research 1/2007

Open Access 01-12-2007 | Research article

Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study

Authors: Laura C Plantinga, Nancy E Fink, Bernard G Jaar, John H Sadler, Nathan W Levin, Josef Coresh, Michael J Klag, Neil R Powe

Published in: BMC Health Services Research | Issue 1/2007

Login to get access

Abstract

Background

Clinical performance targets are intended to improve patient outcomes in chronic disease through quality improvement, but evidence of an association between multiple target attainment and patient outcomes in routine clinical practice is often lacking.

Methods

In a national prospective cohort study (ESRD Quality, or EQUAL), we examined whether attainment of multiple targets in 668 incident hemodialysis patients from 74 U.S. not-for-profit dialysis clinics was associated with better outcomes. We measured whether the following accepted clinical performance targets were met at 6 months after study enrollment: albumin (≥4.0 g/dl), hemoglobin (≥11 g/dl), calcium-phosphate product (<55 mg2/dl2), dialysis dose (Kt/V≥1.2), and vascular access type (fistula). Outcomes included mortality, hospital admissions, hospital days, and hospital costs.

Results

Attainment of each of the five targets was associated individually with better outcomes; e.g., patients who attained the albumin target had decreased mortality [relative hazard (RH) = 0.55, 95% confidence interval (CI), 0.41–0.75], hospital admissions [incidence rate ratio (IRR) = 0.67, 95% CI, 0.62–0.73], hospital days (IRR = 0.61, 95% CI, 0.58–0.63), and hospital costs (average annual cost reduction = $3,282, P = 0.002), relative to those who did not. Increasing numbers of targets attained were also associated, in a graded fashion, with decreased mortality (P = 0.030), fewer hospital admissions and days (P < 0.001 for both), and lower costs (P = 0.029); these trends remained statistically significant for all outcomes after adjustment (P < 0.001), except cost, which was marginally significant (P = 0.052).

Conclusion

Attainment of more clinical performance targets, regardless of which targets, was strongly associated with decreased mortality, hospital admissions, and resource use in hemodialysis patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Crossing the Quality Chasm: A New Health System for the 21st Century. Edited by: Committee on Quality of Health Care in America IM. 2001, Washington, DC, National Academy Press Crossing the Quality Chasm: A New Health System for the 21st Century. Edited by: Committee on Quality of Health Care in America IM. 2001, Washington, DC, National Academy Press
2.
go back to reference Lowrie EG, Teng M, Lacson E, Lew N, Lazarus JM, Owen WF: Association between prevalent care process measures and facility-specific mortality rates. Kidney Int. 2001, 60: 1917-1929. 10.1046/j.1523-1755.2001.00029.x.PubMedCrossRef Lowrie EG, Teng M, Lacson E, Lew N, Lazarus JM, Owen WF: Association between prevalent care process measures and facility-specific mortality rates. Kidney Int. 2001, 60: 1917-1929. 10.1046/j.1523-1755.2001.00029.x.PubMedCrossRef
3.
go back to reference Lacson E, Teng M, Lazarus JM, Lew N, Lowrie E, Owen W: Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis. Am J Kidney Dis. 2001, 37: 267-275.PubMedCrossRef Lacson E, Teng M, Lazarus JM, Lew N, Lowrie E, Owen W: Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis. Am J Kidney Dis. 2001, 37: 267-275.PubMedCrossRef
5.
go back to reference Lowrie EG, Huang WH, Lew NL: Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney Dis. 1995, 26: 220-228.PubMedCrossRef Lowrie EG, Huang WH, Lew NL: Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney Dis. 1995, 26: 220-228.PubMedCrossRef
6.
go back to reference Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993, 3: 1613-1622.PubMedCrossRef Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, Avram MM: Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993, 3: 1613-1622.PubMedCrossRef
7.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996, 7: 728-736.PubMedCrossRef Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996, 7: 728-736.PubMedCrossRef
8.
go back to reference Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis. 1995, 26: 209-219.PubMedCrossRef Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis. 1995, 26: 209-219.PubMedCrossRef
9.
go back to reference Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993, 329: 1001-1006. 10.1056/NEJM199309303291404.PubMedCrossRef Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993, 329: 1001-1006. 10.1056/NEJM199309303291404.PubMedCrossRef
10.
go back to reference Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005, 68: 766-772. 10.1111/j.1523-1755.2005.00455.x.PubMedCrossRef Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005, 68: 766-772. 10.1111/j.1523-1755.2005.00455.x.PubMedCrossRef
11.
go back to reference Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998, 31: 607-617.PubMedCrossRef Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998, 31: 607-617.PubMedCrossRef
12.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996, 28: 53-61.PubMedCrossRef Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996, 28: 53-61.PubMedCrossRef
13.
go back to reference Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ: Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis. 2004, 44: 27-33. 10.1053/j.ajkd.2004.08.008.PubMedCrossRef Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ: Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis. 2004, 44: 27-33. 10.1053/j.ajkd.2004.08.008.PubMedCrossRef
14.
go back to reference Rao M, Pereira BJ: Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease. Kidney Int. 2005, 68: 1432-1438. 10.1111/j.1523-1755.2005.00554.x.PubMedCrossRef Rao M, Pereira BJ: Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease. Kidney Int. 2005, 68: 1432-1438. 10.1111/j.1523-1755.2005.00554.x.PubMedCrossRef
15.
go back to reference Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis. 1994, 23: 272-282.PubMedCrossRef Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis. 1994, 23: 272-282.PubMedCrossRef
16.
go back to reference Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 1994, 23: 661-669.PubMedCrossRef Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 1994, 23: 661-669.PubMedCrossRef
17.
go back to reference Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int. 1996, 50: 550-556.PubMedCrossRef Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int. 1996, 50: 550-556.PubMedCrossRef
18.
go back to reference Frankenfield DL, McClellan WM, Helgerson SD, Lowrie EG, Rocco MV, Owen WF: Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 National ESRD Core Indicators Project. Am J Kidney Dis. 1999, 33: 584-591.PubMedCrossRef Frankenfield DL, McClellan WM, Helgerson SD, Lowrie EG, Rocco MV, Owen WF: Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 National ESRD Core Indicators Project. Am J Kidney Dis. 1999, 33: 584-591.PubMedCrossRef
19.
go back to reference Elseviers MM, Van Waeleghem JP: Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Nephrol News Issues. 2003, 17: 61-8, 99.PubMed Elseviers MM, Van Waeleghem JP: Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Nephrol News Issues. 2003, 17: 61-8, 99.PubMed
20.
go back to reference Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999, 55: 1081-1090. 10.1046/j.1523-1755.1999.0550031081.x.PubMedCrossRef Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int. 1999, 55: 1081-1090. 10.1046/j.1523-1755.1999.0550031081.x.PubMedCrossRef
21.
go back to reference Port FK, Pisoni RL, Bragg-Gresham JL, Satayathum SS, Young EW, Wolfe RA, Held PJ: DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004, 22: 175-180. 10.1159/000074938.PubMedCrossRef Port FK, Pisoni RL, Bragg-Gresham JL, Satayathum SS, Young EW, Wolfe RA, Held PJ: DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004, 22: 175-180. 10.1159/000074938.PubMedCrossRef
22.
go back to reference Himmelfarb J, Pereira BJ, Wesson DE, Smedberg PC, Henrich WL: Payment for quality in end-stage renal disease. J Am Soc Nephrol. 2004, 15: 3263-3269. 10.1097/01.ASN.0000145893.61791.7B.PubMedCrossRef Himmelfarb J, Pereira BJ, Wesson DE, Smedberg PC, Henrich WL: Payment for quality in end-stage renal disease. J Am Soc Nephrol. 2004, 15: 3263-3269. 10.1097/01.ASN.0000145893.61791.7B.PubMedCrossRef
23.
go back to reference O'Connor AS, Wish JB, Sehgal AR: The morbidity and cost implications of hemodialysis clinical performance measures. Hemodial Int. 2005, 9: 349-361. 10.1111/j.1542-4758.2005.01153.x.PubMedCrossRef O'Connor AS, Wish JB, Sehgal AR: The morbidity and cost implications of hemodialysis clinical performance measures. Hemodial Int. 2005, 9: 349-361. 10.1111/j.1542-4758.2005.01153.x.PubMedCrossRef
24.
go back to reference Sehgal AR, Dor A, Tsai AC: Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis. 2001, 37: 1223-1231.PubMedCrossRef Sehgal AR, Dor A, Tsai AC: Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis. 2001, 37: 1223-1231.PubMedCrossRef
25.
go back to reference Powe NR, Klag MJ, Sadler JH, Anderson GF, Bass EB, Briggs WA, Fink NE, Levey AS, Levin NW, Meyer KB, Rubin HR, Wu AW: Choices for healthy outcomes in caring for end stage renal disease. Semin Dial. 1996, 9: 9-11.CrossRef Powe NR, Klag MJ, Sadler JH, Anderson GF, Bass EB, Briggs WA, Fink NE, Levey AS, Levin NW, Meyer KB, Rubin HR, Wu AW: Choices for healthy outcomes in caring for end stage renal disease. Semin Dial. 1996, 9: 9-11.CrossRef
26.
go back to reference Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001, 38: 494-501.PubMedCrossRef Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001, 38: 494-501.PubMedCrossRef
27.
go back to reference Daugirdas JT: Second-generation logarithmic estimates of single-pool variable volume of Kt/V: an analysis of error. J Am Soc Nephrol. 1993, 4: 1204-1213.CrossRef Daugirdas JT: Second-generation logarithmic estimates of single-pool variable volume of Kt/V: an analysis of error. J Am Soc Nephrol. 1993, 4: 1204-1213.CrossRef
29.
go back to reference Greenfield S, Apolone G, McNeil BJ, Cleary PD: The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993, 31: 141-154. 10.1097/00005650-199302000-00005.PubMedCrossRef Greenfield S, Apolone G, McNeil BJ, Cleary PD: The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993, 31: 141-154. 10.1097/00005650-199302000-00005.PubMedCrossRef
30.
go back to reference Athienites NV, Miskulin DC, Fernandez G, Bunnapradist S, Simon G, Landa M, Schmid CH, Greenfield S, Levey AS, Meyer KB: Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial. 2000, 13: 320-326. 10.1046/j.1525-139x.2000.00095.x.PubMedCrossRef Athienites NV, Miskulin DC, Fernandez G, Bunnapradist S, Simon G, Landa M, Schmid CH, Greenfield S, Levey AS, Meyer KB: Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial. 2000, 13: 320-326. 10.1046/j.1525-139x.2000.00095.x.PubMedCrossRef
31.
go back to reference Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, Fink NE, Coresh J, Powe NR, Klag MJ, Levey AS: Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis. 2000, 39: 324-336.CrossRef Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, Fink NE, Coresh J, Powe NR, Klag MJ, Levey AS: Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis. 2000, 39: 324-336.CrossRef
32.
go back to reference Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS: Comorbidity assessment using the Index of Coexistent Diseases in a multi-center clinical trial. Kidney Int. 2001, 60: 1498-1510. 10.1046/j.1523-1755.2001.00954.x.PubMedCrossRef Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS: Comorbidity assessment using the Index of Coexistent Diseases in a multi-center clinical trial. Kidney Int. 2001, 60: 1498-1510. 10.1046/j.1523-1755.2001.00954.x.PubMedCrossRef
33.
go back to reference Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002, 137: 479-486.PubMedCrossRef Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002, 137: 479-486.PubMedCrossRef
34.
go back to reference Plantinga LC, Fink NE, Sadler JH, Levey AS, Levin NW, Rubin HR, Coresh J, Klag MJ, Powe NR: Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol. 2004, 15: 210-218. 10.1097/01.ASN.0000106101.48237.9D.PubMedCrossRef Plantinga LC, Fink NE, Sadler JH, Levey AS, Levin NW, Rubin HR, Coresh J, Klag MJ, Powe NR: Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol. 2004, 15: 210-218. 10.1097/01.ASN.0000106101.48237.9D.PubMedCrossRef
35.
go back to reference Plantinga LC, Fink NE, Jaar BG, Sadler JH, Coresh J, Klag MJ, Levey AS, Powe NR: Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. J Am Soc Nephrol. 2004, 15: 3144-3153. 10.1097/01.ASN.0000146424.91128.2A.PubMedCrossRef Plantinga LC, Fink NE, Jaar BG, Sadler JH, Coresh J, Klag MJ, Levey AS, Powe NR: Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. J Am Soc Nephrol. 2004, 15: 3144-3153. 10.1097/01.ASN.0000146424.91128.2A.PubMedCrossRef
36.
go back to reference Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997, 127: 757-763.PubMedCrossRef Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997, 127: 757-763.PubMedCrossRef
37.
go back to reference O'Connor AS, Wish JB, Sehgal AR: The morbidity and cost implications of hemodialysis clinical performance measures. Hemodial Int. 2005, 9: 349-361. 10.1111/j.1542-4758.2005.01153.x.PubMedCrossRef O'Connor AS, Wish JB, Sehgal AR: The morbidity and cost implications of hemodialysis clinical performance measures. Hemodial Int. 2005, 9: 349-361. 10.1111/j.1542-4758.2005.01153.x.PubMedCrossRef
38.
go back to reference Sehgal AR, Dor A, Tsai AC: Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis. 2001, 37: 1223-1231.PubMedCrossRef Sehgal AR, Dor A, Tsai AC: Morbidity and cost implications of inadequate hemodialysis. Am J Kidney Dis. 2001, 37: 1223-1231.PubMedCrossRef
39.
go back to reference Centers for Medicare & Medicaid Services: 2004 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. 2004, Baltimore, MD, Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality Centers for Medicare & Medicaid Services: 2004 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. 2004, Baltimore, MD, Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality
40.
go back to reference System USRD: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2005, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases System USRD: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2005, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
41.
go back to reference Longo DR, Everet KD: Health care consumer reports: an evaluation of consumer perspectives. J Health Care Finance. 2003, 30: 65-71.PubMed Longo DR, Everet KD: Health care consumer reports: an evaluation of consumer perspectives. J Health Care Finance. 2003, 30: 65-71.PubMed
42.
go back to reference Longo DR, Land G, Schramm W, Fraas J, Hoskins B, Howell V: Consumer reports in health care. Do they make a difference in patient care?. JAMA. 1997, 278: 1579-1584. 10.1001/jama.278.19.1579.PubMedCrossRef Longo DR, Land G, Schramm W, Fraas J, Hoskins B, Howell V: Consumer reports in health care. Do they make a difference in patient care?. JAMA. 1997, 278: 1579-1584. 10.1001/jama.278.19.1579.PubMedCrossRef
43.
go back to reference Hannan EL, Kumar D, Racz M, Siu AL, Chassin MR: New York State's Cardiac Surgery Reporting System: four years later. Ann Thorac Surg. 1994, 58: 1852-1857.PubMedCrossRef Hannan EL, Kumar D, Racz M, Siu AL, Chassin MR: New York State's Cardiac Surgery Reporting System: four years later. Ann Thorac Surg. 1994, 58: 1852-1857.PubMedCrossRef
45.
go back to reference Goldfield N, Burford R, Averill R, Boissonnault B, Kelly W, Kravis T, Smithline N: Pay for performance: an excellent idea that simply needs implementation. Qual Manag Health Care. 2005, 14: 31-44.PubMedCrossRef Goldfield N, Burford R, Averill R, Boissonnault B, Kelly W, Kravis T, Smithline N: Pay for performance: an excellent idea that simply needs implementation. Qual Manag Health Care. 2005, 14: 31-44.PubMedCrossRef
Metadata
Title
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study
Authors
Laura C Plantinga
Nancy E Fink
Bernard G Jaar
John H Sadler
Nathan W Levin
Josef Coresh
Michael J Klag
Neil R Powe
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2007
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-7-5

Other articles of this Issue 1/2007

BMC Health Services Research 1/2007 Go to the issue